Skip to content

SN · Pharma and healthcare · one day

Smith & Nephew (SN): news on Friday 23 October 2026

News from the 24 hours to Friday morning, 23 October 2026.

Tone of the day

−3.7negative
Relevant headlines7of 9 read
Stories4grouped by event

What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

Why it scored this way

Coverage was dominated by the collapse of merger talks with J&J's orthopaedics unit over a leadership dispute, which weighs on the outlook. Some offset came from the Xodus Medical purchase, a firmer share price and confirmation of the interim dividend.

What drove it

  • collapsed J&J merger talks
  • Xodus Medical acquisition
  • interim dividend

Around this day

DayToneHeadlines
Sat 17 Oct+1.31
Mon 19 Oct−6.32
Tue 20 Oct−0.73
Wed 21 Oct+0.34
Thu 22 Oct+3.22
Fri 23 Oct−3.77
Sat 24 Oct−5.721
Sun 25 Oct−2.03
Mon 26 Oct−1.24

4 stories · 7 headlines · strongest first

Pharma and healthcare on 23 OctoberFTSE 100 that day
ToneHeadline and why it scored that wayOutlet
Smith & Nephew merger talks with J&J orthopaedics unit collapse −4.93 headlines today · 28 in all · Reports say talks on a $34bn deal with J&J's orthopaedics unit collapsed over a leadership dispute.
−7.5Smith & Nephew merger talks with J&J orthopaedics unit collapse over leadership disputeMerger talks with J&J orthopaedics unit collapsed over leadership dispute.Traders Union
−6.7How a transatlantic mega-merger fell apart over a leadership tug of warMega-merger fell apart over leadership tug of war.FT Companies
−6.7The dispute that blew up a $34bn dealAnalysis of the $34bn deal blowing up over a dispute.Financial Times
Smith & Nephew announces 15.6-cent interim dividend payable 6 November +1.72 headlines today · Notices report a 15.6-cent interim dividend payable on 6 November 2026, with the sterling amount announced.
+2.5A 15.6-cent interim dividend from Smith & Nephew (SNN) is payable November 6, 2026.Interim dividend confirmed as payable; routine but supportive.Stock Titan
+0.8REG - Smith & Nephew Plc - Sterling Amount of DividendRoutine dividend sterling amount notice.TradingView
Smith & Nephew Acquires Xodus Medical to Enhance Product Portfolio +7.51 headline today · 2 in all, since 13 October · A Kalkine piece looks at why the stock is in focus after the Xodus Medical purchase.
+6.3Why Is Smith & Nephew (LSE:SN) Stock Back In Focus This Week After Buying Xodus Medical?Acquisition of Xodus Medical puts the stock back in focus.Kalkine Media
Smith & Nephew shares firm as healthcare draws buyers +4.21 headline today · Kalkine reports the shares firmed as healthcare drew buyers.
+4.2Smith & Nephew (LSE:SN.) Firms as Healthcare Draws BuyersShares firming as buyers return to healthcare; mildly positive.Kalkine Media

Each headline has its own score; the links go to the publisher.

Follow by email

A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 26 October · 326 headlines · 63 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · RSS · API · llms.txt